Mwandishi:
ULY CLINIC
Mhariri:
ULY CLINIC
Imeboreshwa:
20 Oktoba 2026, 15:06:27
Management of Ingested Poisons
Management of ingested poisons
Ingestion is the most common route of poisoning worldwide. Toxic exposure should be suspected in any patient presenting with unexplained altered mental status, metabolic derangement, or multi-system symptoms, regardless of a reported history of ingestion.
Ingested toxins are suspected in any patient with signs and symptoms irrespective of reported dose ingested.
Poisoning severity depends on
Type of toxin (drug, pesticide, hydrocarbon, plant, heavy metal)
Dose and concentration
Time since ingestion
Co-ingestion (alcohol or multiple drugs)
Patient age, comorbidities, and nutritional status
Risk factors
Patient-related
Children <5 years (exploratory ingestion)
Adolescents (intentional self-harm)
Psychiatric illness
Substance abuse
Elderly with polypharmacy
Chronic kidney or liver disease
Environmental
Improper storage of chemicals
Use of unlabeled containers
Agricultural pesticides in households
Traditional/herbal medicines
Drug-related
Narrow therapeutic index drugs
Sustained-release formulations
Polypharmacy interactions
Clinical presentations
General clinical features
Nausea
Vomiting
Drowsiness
Blurred vision
Dizziness
Central nervous system toxicity
Altered level of consciousness
Acute confusion
Convulsions
Coma
Renal toxicity
Acute kidney injury/failure
Papillary necrosis
Oliguria or anuria
Metabolic derangement
Metabolic acidosis
Respiratory acidosis
Hypoglycemia
Allergic reactions
Urticaria
Angioedema
Anaphylaxis
Hematological toxicity
Aplastic anemia
Agranulocytosis
Diagnostic criteria
Diagnosis is clinical and laboratory supportive:
History or suspicion of ingestion
Compatible toxidrome
Laboratory abnormalities
Exclusion of other causes
Recognition of toxidromes
Toxidrome | Key findings | Examples |
Cholinergic | Salivation, sweating, diarrhea, miosis | Organophosphates |
Anticholinergic | Dry skin, delirium, tachycardia | Antihistamines |
Opioid | Pinpoint pupils, respiratory depression | Morphine |
Sympathomimetic | Agitation, hypertension, hyperthermia | Amphetamines |
Sedative-hypnotic | CNS depression, normal pupils | Benzodiazepines |
Investigations
Initial emergency tests (all patients)
Blood glucose (immediate bedside)
Arterial blood gas
Serum electrolytes
Renal function tests
Liver function tests
Complete blood count
Urinalysis
Toxicology investigations
Serum drug levels (paracetamol, salicylate, lithium)
Blood alcohol level
Toxicology screen (if available)
Additional tests
ECG (cardiotoxic drugs)
Serum osmolality and osmolar gap
Lactate
Coagulation profile
Pregnancy test in females
Imaging
Chest X-ray (aspiration)
Abdominal X-ray (metal ingestion, drug packets)
CT brain if persistent coma
Treatment
Non-pharmacological management
Initial stabilization (always first)
Airway – Breathing – Circulation (ABC):
Secure airway
Provide oxygen
IV access and fluids
Monitor ECG
Correct hypoglycemia immediately
Control seizures
Gastrointestinal decontamination
Gastrointestinal decontamination is the practice of removing an ingested toxin from the gastrointestinal tract to decrease absorption. It includes gastric evacuation (forced emesis or gastric lavage), intra-gastric binding (single or multidose activated charcoal), or speeding transit of toxins (whole bowel irrigation or cathartics).
It is most beneficial within 1–2 hours of ingestion.
Gastric lavage
May be considered in selected cases.
Procedure (general care)
Keep patient under observation for 4–24 hours depending on toxin
Position: left lateral, head down
Insert large nasogastric tube
Use warm 0.9% saline repeatedly until clear return
Suction ready; intubate if aspiration risk
Contraindications
Unprotected airway in unconscious patient
Ingestion of corrosives or petroleum products (e.g. kerosene)
Bowel obstruction
Bowel perforation
Gastrointestinal bleeding
Important notes
Forced vomiting is not recommended and is highly discouraged.
Gastric lavage only in life-threatening poisoning within 30 minutes to 1 hour of ingestion, when no safer alternative is available.
Whole bowel irrigation may be considered in selected cases; routine cathartics are not recommended.
Treatment works best within 1 hour of the poisoning.
For kerosene, petrol or petrol-based products (including most pesticide solvents), or mouth and throat burns (bleach, toilet cleaner, battery acid), do not make the patient vomit; give water by mouth.
Never use salt as an emetic: it can be fatal.
If charcoal is not available, induce vomiting only in a conscious patient (by rubbing the back of the throat with a spatula or spoon handle).
Pharmacological treatment
Activated charcoal (single dose)
Within 1 hour of ingestion of adsorbable toxins
Given orally or via NG tube
Dose
Children <1 year: 1 g/kg
Children 1–12 years: 25–50 g
Adolescents/adults: 25–100 g
Administration
Mix in 8–10× water
Give orally or NG tube
If intolerance occurs, divide dose
Contraindications
Corrosives
Hydrocarbons
Ileus or obstruction
Unprotected airway
Multiple-dose activated charcoal (indicated toxins)
Carbamazepine
Dapsone
Digoxin
Paraquat
Phenobarbitone
Quinine
Slow-release theophylline
Amanita phalloides
A: Activated charcoal (PO or NG tube), single dose, within 1 hour of ingestion, only if the airway is protected: children below 1 year 1 g/kg; children 1–12 years 25–50 g; adolescents and adults 25–100 g.
Mix the charcoal in 8–10 times its amount of water (for example 5 g in 40 ml); give it all at once, or divide the dose if the child cannot tolerate it.
Multiple doses of activated charcoal are indicated for carbamazepine, dapsone, digoxin, paraquat, phenobarbitone, quinine, slow-release preparations such as theophylline, and Amanita phalloides mushrooms, and may be considered in life-threatening overdose of other drugs such as tricyclic antidepressants.
Do not give activated charcoal for corrosives or petroleum products (kerosene, petrol).
Fluids
Compound sodium lactate or 0.9% sodium chloride (IV) 30 mL/kg (up to 2 liters over 24 hours) if shock is present
Specific antidotes
Poison | Antidote and dose (STG 2026) |
Organophosphates (malathion, dichlorvos, dimethoate and others) | A: Atropine 2–5 mg IV (adults) or 0.05 mg/kg IV (children), doubling every 3–5 minutes until atropinised (dry secretions, heart rate above 80, systolic BP above 80 mmHg) AND S: pralidoxime 1–2 g IV over 15–30 minutes, repeat after 1 hour then 12-hourly as needed, OR 30 mg/kg IV over 20 minutes then 4–8 mg/kg/hour |
Carbamates (propoxur, aldicarb, carbaryl, carbofuran, methomyl) | A: Atropine 2–5 mg IV (adults) or 0.05 mg/kg IV (children), titrated to atropinisation; pralidoxime is usually not needed for carbamates |
Organochlorines (endosulfan, lindane, heptachlor, chlordane) | Supportive care |
Anticoagulant rodenticides (bromadiolone) | B: Phytomenadione (vitamin K1) 2.5–10 mg PO/SC in adults, up to 25–50 mg if needed, repeated every 12–48 hours; S: cholestyramine 4 g PO every 12–24 hours (maintenance 8–16 g/day, maximum 24 g/day) |
Arsenic | D: Dimercaprol 3 mg/kg IM every 4 hours for 48 hours, then 3 mg/kg every 12 hours for 10 days AND D: penicillamine 30–40 mg/kg/day PO for 1–6 months (2 hours before or 3 hours after food) |
Methanol | Ethanol: loading 600 mg/kg IV or 600–700 mg/kg PO/NG (diluted); maintenance 0.15 ml/kg/hour (IV: 1.4 ml/kg/hour of 10% ethanol) |
Ethylene glycol (antifreeze) | Ethanol as for methanol AND S: folinic acid 60 mg IM once, then 15 mg PO every 8 hours for 48–72 hours AND C: thiamine 100 mg IV once, then 50–100 mg/day IM/IV |
Cyanide | C: Hydroxocobalamin 70 mg/kg IV (usually 5 g) over 15 minutes; repeat 5 g if needed |
Methaemoglobinaemia (nitrites, nitrates, dapsone, aniline, naphthalene) | C: Methylene blue 1 mg/kg IV over 5–30 minutes; repeat after 1 hour if methaemoglobin is above 30% or symptoms persist |
Paracetamol | C: N-acetylcysteine (IV 21-hour regimen; oral 140 mg/kg loading, then 70 mg/kg every 4 hours for 3 days) |
Iron | D: Deferoxamine 50 mg/kg IM every 4–12 hours (moderate) or 15 mg/kg/hour IV infusion (severe) |
Benzodiazepines | D: Flumazenil 0.2 mg IV over 15 seconds, then 0.1 mg every 60 seconds until awake (usual total 0.3–0.6 mg) |
Opioids | B: Naloxone 0.4–2 mg IV, repeated every 2–3 minutes as needed |
Isoniazid | B: Pyridoxine 10–25 mg PO every 8 hours for 48 hours |
Digoxin | S: Digoxin immune Fab (1 vial binds 0.5 mg digoxin) |
Datura (anticholinergic plant) | S: Physostigmine 0.5–2 mg IV slowly (maximum 1 mg/min), repeat after 20 minutes if needed; maintenance 1–4 mg every 30–60 minutes as needed |
Snake bite | A: Polyvalent snake venom antiserum IV: mild 5 vials, moderate 5–10 vials, severe 10–20 vials |
Dog bite (rabies exposure) | B: Human rabies immunoglobulin, half infiltrated into the wound and half IM/SC |
Botulism | S: Botulinum antitoxin IV, starting at 0.5 ml/min for 30 minutes, then slowly with monitoring for hypersensitivity |
Supportive therapy
IV fluids
Electrolyte correction
Benzodiazepines for seizures
Vasopressors for shock
Mechanical ventilation if needed
Hemodialysis for dialyzable toxins
Prevention
Do’s
Store medicines safely
Use child-resistant containers
Keep products in original packaging
Read labels carefully
Don’ts
Do not transfer chemicals into drink bottles
Do not leave containers open
Do not remove labels
Do not refer to medicines as sweets
Avoid taking medicine in front of small children
Referral
Consider transfer to higher-level care if:
Unconscious or deteriorating level of consciousness
Burns to the mouth and throat
Severe respiratory distress
Cyanosis
Heart failure
Call the National Poison Control Centre on the toll-free number 0800 112031 for advice.
